ProfileGDS5678 / 1426348_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 96% 97% 97% 96% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.498898
GSM967853U87-EV human glioblastoma xenograft - Control 210.401898
GSM967854U87-EV human glioblastoma xenograft - Control 310.497598
GSM967855U87-EV human glioblastoma xenograft - Control 410.584698
GSM967856U87-EV human glioblastoma xenograft - Control 510.687298
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 18.7078596
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.9274797
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.2145497
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 48.8983496
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.944799
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.187399
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.919499
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.223599
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.890499